🇺🇸 Ezetimibe Tablets in United States

166 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Coronary Artery Disease — 37 reports (22.29%)
  2. Myocardial Infarction — 35 reports (21.08%)
  3. Angina Unstable — 21 reports (12.65%)
  4. Drug Ineffective — 17 reports (10.24%)
  5. Myalgia — 15 reports (9.04%)
  6. Drug Intolerance — 10 reports (6.02%)
  7. Malaise — 9 reports (5.42%)
  8. Drug Interaction — 8 reports (4.82%)
  9. Anaphylactic Reaction — 7 reports (4.22%)
  10. Fatigue — 7 reports (4.22%)

Source database →

Ezetimibe Tablets in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Ezetimibe Tablets approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Ezetimibe Tablets in United States?

NYU Langone Health is the originator. The local marketing authorisation holder may differ — check the official source linked above.